Eli Lilly to acquire biotechnology company for $2.9B
Indianapolis-based Eli Lilly has signed a definitive agreement to acquire Cambridge, Mass.-based Merida Biosciences, a biotechnology company aimed at advancing therapeutics for serious autoimmune and allergic diseases, for up to $2.875 billion in cash. The transaction includes an upfront payment and contingent milestone payments, according to an Aug. 31 news release. It is expected to […] The post Eli Lilly to acquire biotechnology company for $2.9B appeared first on Becker's Hospital...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.